Cosentyx 300 MG dose-2 syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FL1BD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,480
Award facts
- Contract value 100% obligated
- $67,479.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67,479.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 4,570 units of Cosentyx 300 mg dose syringes on January 14, 2026, with a completion date of January 15, 2026. This competitive award, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing part of the Defense Health Agency's broader pharmaceutical supply requirements for military treatment facilities and veteran healthcare programs.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999 through December 31, 2031), which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare operations globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs through competitively awarded contracts involving firm fixed-price delivery orders, demonstrating its capability to meet the military health system's requirements for specialty medications and critical care materials across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FL1BD?
SPE2DR26FL1BD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FL1BD worth?
The government has obligated $67,480 on SPE2DR26FL1BD.
Is contract SPE2DR26FL1BD an order under another contract?
Yes. SPE2DR26FL1BD is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1BD competed?
The extent of competition for SPE2DR26FL1BD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award